The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -38,426 |
| Depreciation and amortization | 487 |
| Accretion of debt discount and debt issuance costs | 944 |
| Stock-based compensation expense | 13,054 |
| Allowance for credit losses | 129 |
| Provision (benefit) for excess and obsolete inventories | 0 |
| Noncash operating lease cost | 498 |
| Loss on disposal of property and equipment | -4 |
| Noncash loss on debt extinguishment | 0 |
| Change in fair value of common stock warrants | 11 |
| Accounts receivable | -912 |
| Inventory | 1,442 |
| Prepaid expenses and other current assets | 686 |
| Other noncurrent assets | 150 |
| Accounts payable | -348 |
| Accrued compensation | -3,606 |
| Accrued and other current liabilities | -1,075 |
| Other noncurrent liabilities | 0 |
| Net cash used in operating activities | -29,694 |
| Purchases of property and equipment | 224 |
| Net cash used in investing activities | -224 |
| Net proceeds from hercules loan agreement | 0 |
| Repayment of midcap loan agreement | 0 |
| Debt issuance costs | 0 |
| Proceeds from exercise of common stock options | 1,091 |
| Taxes paid on net settlement of restricted stock units | -58 |
| Proceeds from employee stock purchase plan purchases | 758 |
| Net cash provided by financing activities | 1,791 |
| Net change in cash and cash equivalents | -28,127 |
| Cash and cash equivalents at beginning of period | 120,357 |
| Cash and cash equivalents at end of period | 92,230 |
Sight Sciences, Inc. (SGHT)
Sight Sciences, Inc. (SGHT)